---
$id: https://graph.org.ai/products/commodity/51442205
$type: Product
source: UNSPSC
code: "51442205"
title: "Gadofosveset"
class: "51442200"
classTitle: "Gadolinium-based medical imaging agents, media, and tracers"
family: "51440000"
familyTitle: "Radiopharmaceuticals and contrast media"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Gadofosveset

**UNSPSC Code**: 51442205
**Class**: [Gadolinium-based medical imaging agents, media, and tracers](Gadolinium-based medical imaging agents, media, and tracers.mdx)
**Family**: [Radiopharmaceuticals and contrast media](../Radiopharmaceuticals and contrast media.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a gadolinium-chelate, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E65RW73PHS. The European Medicines Agency schedules Gadofosveset in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25385. Gadofosveset generally arises in the molecular formula C33H38N3O14P.3H+.GD. The term GADOFOSVESET is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 15 no. 1, 2001, list 45.) Most nations schedule Gadofosveset under HS 28469000.

